Stephen Davis Heron Therapeutics, Inc. (HRTX) insider trading activity

HRTX Quotes by TradingView

Stephen Davis is Director of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 52,032 shares of HRTX, which is worth approximately $55,674. The most recent transaction as insider was on Dec 16, 2022, when has been sold 38,580 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52K
0% 3M change
0% 12M change
Total Value Held $55,674

STEPHEN DAVIS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2022
BUY
Grant, award, or other acquisition
-
38,580 Added 42.58%
52,032 Common Stock
Dec 22 2021
BUY
Grant, award, or other acquisition
-
10,452 Added 43.72%
13,452 Common Stock
Dec 21 2020
BUY
Grant, award, or other acquisition
-
3,000 Added 50.0%
3,000 Common Stock

Also insider at

ACAD
ACADIA PHARMACEUTICALS INC Healthcare
CEO
BLCM
BELLICUM PHARMACEUTICALS, INC Healthcare
Director
SD

Stephen Davis

Director
Houston, TX

Track Institutional and Insider Activities on HRTX

Follow HERON THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

News

Receive news related to HERON THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HRTX